Pfizer Canada Inc. Sustainability Profile
Pfizer Canada Inc., a subsidiary of the global pharmaceutical giant Pfizer Inc., is headquartered in Canada and operates extensively across the country. Founded in 1849, Pfizer has established itself as a leader in the pharmaceutical industry, focusing on innovative medicines and vaccines that address critical health needs. With a diverse portfolio that includes treatments for oncology, cardiology, immunology, and rare diseases, Pfizer Canada is renowned for its commitment to research and development. The company’s unique approach to drug discovery and its robust pipeline of products have positioned it as a key player in the Canadian healthcare landscape. Notable achievements include the rapid development of the COVID-19 vaccine, which underscored Pfizer's role in global health. As a trusted name in pharmaceuticals, Pfizer Canada continues to enhance patient outcomes through its cutting-edge therapies and dedication to scientific excellence.
DitchCarbon Score
How does Pfizer Canada Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Pfizer Canada Inc.'s score of 84 is higher than 91% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Pfizer Canada Inc. currently does not have specific carbon emissions data available for the most recent year, as indicated by the absence of emissions figures. However, the company is part of a broader corporate family, with emissions data and climate commitments cascaded from its parent organization, Pfizer Inc. Pfizer Inc. has set ambitious climate targets, which include commitments to reduce greenhouse gas emissions across its operations. These targets are aligned with the Science Based Targets initiative (SBTi) and are part of a comprehensive strategy to address climate change. The initiatives include commitments to renewable energy and sustainable practices, although specific reduction targets for Pfizer Canada Inc. have not been detailed. As a current subsidiary of Pfizer Inc., Pfizer Canada Inc. benefits from the overarching climate strategies and performance metrics established by its parent company. This includes participation in initiatives such as the Carbon Disclosure Project (CDP) and RE100, which focus on transparency and the transition to renewable energy sources. In summary, while specific emissions data for Pfizer Canada Inc. is not available, the company is integrated into Pfizer Inc.'s climate commitments and reduction initiatives, reflecting a strong corporate responsibility towards mitigating climate impact.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 964,846,000 | - | - | - | - | - | - | - | 000,000,000 | - | - | - | 000,000,000 |
| Scope 2 | 883,814,000 | - | - | - | - | - | - | - | 000,000,000 | - | - | - | 000,000,000 |
| Scope 3 | - | - | - | - | - | - | - | 000,000,000 | 0,000,000,000 | 00,000,000 | 00,000,000 | 000,000,000 | 0,000,000,000 |
How Carbon Intensive is Pfizer Canada Inc.'s Industry?
How Carbon Intensive is Pfizer Canada Inc.'s Location?
Pfizer Canada Inc.'s Scope 3 Categories Breakdown
Pfizer Canada Inc.'s Scope 3 emissions, which increased significantly last year and increased by approximately 821% since 2019, demonstrating supply chain emissions tracking. Most of their carbon footprint comes from suppliers and value chain emissions, with Scope 3 emissions accounting for 77% of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 79% of Scope 3 emissions.
Top Scope 3 Categories
Pfizer Canada Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Pfizer Canada Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
